JENNIFER TRAN: Open Payments
NPI 1407360670 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 14 payments from 6 companies in 2025. Trend: 2023 $1,643 · 2024 $426 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $161 |
| Insulet Corporation | 1 | $134 |
| Tandem Diabetes Care, Inc. | 1 | $108 |
| Amgen Inc. | 3 | $55 |
| Eisai Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $18 |
Products named: Omnipod, Sogroya, t:slim X2 Insulin Pump with Control-IQ, Ozempic, Lenvima, EVENITY, TEPEZZA, Wegovy.
Industry payments across TX — which companies pay providers there.
